1-Fluoro-3-bromopropane | CAS:352-91-0

We serve 1-Fluoro-3-bromopropane CAS:352-91-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-Fluoro-3-bromopropane

Chemical Name:1-Fluoro-3-bromopropane
CAS.NO:352-91-0
Synonyms:/
Molecular Formula:C3H6BrF
Molecular Weight:140.98200
 
Physical and Chemical Properties:
Density:1.458
Boiling point:1.458ºC
Flash point:16.4ºC
Index of Refraction:1.4295
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.05%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 1-Fluoro-3-bromopropane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Fluoro-3-bromopropane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Fluoro-3-bromopropane Use and application,1-Fluoro-3-bromopropane technical grade,usp/ep/jp grade.


Related News: APIs are generally manufactured through a variety of processes that include.5-Chloroacetyl-6-chlorooxindole manufacturer With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.tert-Butyl bromoacetate supplier China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.4-Biphenylboronic acid vendor Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes.Though many of the remedies have been in use for hundreds of years, critics argue that there is no verifiable scientific evidence to support their supposed benefits.